FERRIC CARBOXYMALTOSE

FERRIC CARBOXYMALTOSE was reported 4728 times

FERRIC CARBOXYMALTOSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY TEST POSITIVE 1 0.1429
1 HYPOPHOSPHATAEMIA 871 0.1177
2 FIBROBLAST GROWTH FACTOR 23 INCREASED 5 0.0806
3 CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL 1 0.0769
4 BLOOD PHOSPHORUS DECREASED 233 0.0637
5 BINOCULAR VISUAL DYSFUNCTION 2 0.0625
6 CALCIUM IONISED ABNORMAL 1 0.0556
7 PARTNER STRESS 46 0.0480
8 INFUSION SITE DISCOLOURATION 33 0.0375
9 ECTOPIC GASTRIC MUCOSA 1 0.0333
10 SUBMANDIBULAR ABSCESS 2 0.0333
11 INSULIN AUTOIMMUNE SYNDROME 11 0.0308
12 BRAIN NATRIURETIC PEPTIDE 1 0.0250
13 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 2 0.0244
14 HYPOPHOSPHATAEMIC OSTEOMALACIA 6 0.0227
15 AUTOMATIC BLADDER 3 0.0217
16 PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0213
17 ABDOMINAL PANNICULECTOMY 1 0.0204
18 LYMPHADENITIS BACTERIAL 3 0.0200
19 ACUTE PHOSPHATE NEPHROPATHY 3 0.0192
20 HYPOPHOSPHATASIA 2 0.0177
21 EXTRAVASATION 71 0.0173
22 HYPERPHOSPHATURIA 2 0.0171
23 DECREASED INSULIN REQUIREMENT 1 0.0169
24 CEREBRAL HAEMORRHAGE FOETAL 1 0.0164
25 OSTEOMALACIA 22 0.0142
26 HISTONE ANTIBODY POSITIVE 2 0.0128
27 VESTIBULAR MIGRAINE 3 0.0124
28 RENAL TUBULAR DYSFUNCTION 7 0.0124
29 ACCESSORY SPLEEN 1 0.0111
30 IRON OVERLOAD 12 0.0111
31 IMPAIRED SELF-CARE 23 0.0111
32 RENAL SALT-WASTING SYNDROME 4 0.0102
33 TRANSFERRIN DECREASED 2 0.0098
34 ANHEDONIA 254 0.0097
35 SERUM FERRITIN ABNORMAL 3 0.0094
36 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
37 OPISTHOTONUS 7 0.0088
38 SERUM FERRITIN INCREASED 46 0.0087
39 HAEMOPHILIC ARTHROPATHY 2 0.0084
40 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
41 RECTAL ULCER HAEMORRHAGE 2 0.0080
42 ABDOMINAL WALL INFECTION 1 0.0075
43 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
44 TRANSFERRIN SATURATION DECREASED 3 0.0070
45 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
46 INFUSION SITE EXTRAVASATION 39 0.0063
47 BONE HYPERTROPHY 1 0.0062
48 INFUSION SITE URTICARIA 4 0.0060
49 BONE ATROPHY 1 0.0059
50 TRANSFERRIN SATURATION INCREASED 2 0.0058
51 ANGIODYSPLASIA 2 0.0055
52 BLOOD ZINC DECREASED 1 0.0055
53 HER2 POSITIVE BREAST CANCER 2 0.0053
54 CARDIORENAL SYNDROME 3 0.0052
55 STOMA SITE EXTRAVASATION 2 0.0052
56 DRUG MONITORING PROCEDURE NOT PERFORMED 9 0.0050
57 DUODENAL POLYP 1 0.0047
58 SERUM FERRITIN DECREASED 8 0.0046
59 SYSTOLIC HYPERTENSION 2 0.0046
60 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 3 0.0045
61 VEIN DISCOLOURATION 2 0.0043
62 CRANIAL NERVE PARALYSIS 2 0.0042
63 GRAFT VERSUS HOST DISEASE IN LUNG 2 0.0042
64 TUMOUR NECROSIS 4 0.0038
65 CATHETER SITE THROMBOSIS 1 0.0036
66 REPETITIVE SPEECH 2 0.0036
67 AGONAL RESPIRATION 1 0.0035
68 CHONDROMALACIA 1 0.0035
69 ROTAVIRUS INFECTION 2 0.0035
70 DENTAL NECROSIS 1 0.0034
71 HYPERPARATHYROIDISM 7 0.0034
72 CATHETER SITE HAEMATOMA 1 0.0034
73 BED REST 1 0.0032
74 BLOOD IRON ABNORMAL 3 0.0031
75 HYPOVITAMINOSIS 4 0.0030
76 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
77 DERMOID CYST 1 0.0030
78 ONYCHALGIA 3 0.0030
79 SEIZURE LIKE PHENOMENA 5 0.0029
80 INFUSION SITE RASH 4 0.0029
81 ADMINISTRATION SITE BRUISE 1 0.0029
82 INFUSION SITE PAIN 37 0.0029
83 CERVICAL RADICULOPATHY 2 0.0028
84 STRESS FRACTURE 15 0.0028
85 BLOOD PARATHYROID HORMONE INCREASED 8 0.0027
86 COMA HEPATIC 2 0.0027
87 CATHETER SITE DISCHARGE 3 0.0027
88 IRON DEFICIENCY 12 0.0027
89 BLOOD IRON INCREASED 5 0.0027
90 CERVICAL POLYP 1 0.0026
91 FOLATE DEFICIENCY 3 0.0026
92 STOMACH MASS 2 0.0025
93 DEVICE COLOUR ISSUE 1 0.0025
94 VESTIBULAR DISORDER 3 0.0024
95 PRODUCT QUALITY ISSUE 326 0.0024
96 EAR SWELLING 5 0.0024
97 VASOCONSTRICTION 2 0.0023
98 INTESTINAL PSEUDO-OBSTRUCTION 2 0.0023
99 BLOOD IRON DECREASED 27 0.0023
100 DEGENERATIVE BONE DISEASE 1 0.0023
101 BLOOD ALBUMIN INCREASED 2 0.0022
102 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
103 SIALOADENITIS 3 0.0022
104 INJECTION SITE DISCOLOURATION 27 0.0022
105 PHARYNGEAL HYPOAESTHESIA 2 0.0022
106 EHLERS-DANLOS SYNDROME 1 0.0022
107 EMOTIONAL DISTRESS 259 0.0021
108 GLOMERULAR FILTRATION RATE ABNORMAL 3 0.0021
109 SKIN DISCOLOURATION 97 0.0021
110 DISCOLOURED VOMIT 2 0.0021
111 ARTERIOVENOUS FISTULA 1 0.0020
112 ELECTROLYTE DEPLETION 1 0.0020
113 ILL-DEFINED DISORDER 122 0.0020
114 NEONATAL RESPIRATORY DISTRESS SYNDROME 7 0.0020
115 ANAPHYLACTOID REACTION 8 0.0019
116 INFUSION SITE DISCOMFORT 2 0.0019
117 INFUSION RELATED REACTION 127 0.0019
118 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
119 PHARYNGEAL PARAESTHESIA 3 0.0019
120 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
121 INJECTION RELATED REACTION 3 0.0018
122 VITAMIN D DEFICIENCY 17 0.0017
123 LUMBAR RADICULOPATHY 2 0.0017
124 FLUSHING 175 0.0017
125 URTICARIA 288 0.0017
126 INFUSION SITE DISCHARGE 3 0.0017
127 THROAT TIGHTNESS 45 0.0017
128 HYPOCALCAEMIA 31 0.0016
129 CHEST DISCOMFORT 165 0.0016
130 CORTISOL INCREASED 1 0.0016
131 NOCTURNAL DYSPNOEA 2 0.0016
132 CALCIUM DEFICIENCY 2 0.0015
133 ABDOMINAL WALL ABSCESS 1 0.0015
134 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
135 SINUS ARRHYTHMIA 2 0.0015
136 DELIVERY 1 0.0015
137 BONE DEFORMITY 1 0.0015
138 ANAPHYLACTIC REACTION 80 0.0014
139 ARACHNOIDITIS 1 0.0014
140 ANASTOMOTIC LEAK 1 0.0014
141 IRON DEFICIENCY ANAEMIA 13 0.0014
142 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
143 INFUSION SITE BRUISING 3 0.0014
144 BITE 1 0.0014
145 THROAT IRRITATION 62 0.0014
146 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
147 APALLIC SYNDROME 1 0.0014
148 INJECTION SITE EXTRAVASATION 17 0.0014
149 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
150 BACTERIAL DISEASE CARRIER 1 0.0014
151 BONE PAIN 80 0.0014
152 DRUG-DISEASE INTERACTION 1 0.0014
153 RED BLOOD CELL COUNT ABNORMAL 2 0.0014
154 NORMOCYTIC ANAEMIA 2 0.0014
155 BLISTER RUPTURE 1 0.0013
156 AXILLARY PAIN 2 0.0013
157 ORAL PRURITUS 3 0.0013
158 CYTOMEGALOVIRUS COLITIS 3 0.0013
159 INFUSION SITE SWELLING 8 0.0013
160 INFUSION SITE PRURITUS 4 0.0013
161 CARTILAGE ATROPHY 1 0.0012
162 BALANOPOSTHITIS 1 0.0012
163 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
164 SEBORRHOEIC DERMATITIS 2 0.0012
165 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
166 ADRENAL MASS 1 0.0012
167 MYALGIA 205 0.0012
168 VEIN RUPTURE 2 0.0012
169 CARDIAC FAILURE CHRONIC 5 0.0012
170 MEAN CELL VOLUME INCREASED 3 0.0012
171 CRANIOFACIAL FRACTURE 1 0.0012
172 EAR PRURITUS 4 0.0011
173 CATHETER SITE PRURITUS 1 0.0011
174 WEIGHT BEARING DIFFICULTY 3 0.0011
175 UTERINE SPASM 2 0.0011
176 PALPITATIONS 128 0.0011
177 CERUMEN IMPACTION 1 0.0011
178 BONE CONTUSION 1 0.0011
179 BIOPSY 1 0.0011
180 ADENOCARCINOMA GASTRIC 1 0.0011
181 TUNNEL VISION 2 0.0011
182 RENAL TUBULAR DISORDER 3 0.0011
183 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
184 CHEST PAIN 193 0.0010
185 PARAESTHESIA ORAL 15 0.0010
186 MATERNAL EXPOSURE DURING PREGNANCY 92 0.0010
187 ANXIETY 293 0.0010
188 ANIMAL SCRATCH 1 0.0010
189 PRESYNCOPE 25 0.0010
190 STRIDOR 3 0.0010
191 BLADDER CANCER RECURRENT 1 0.0010
192 BRAIN HYPOXIA 1 0.0010
193 DILATED CARDIOMYOPATHY 1 0.0010
194 ADVERSE REACTION 13 0.0010
195 BREAST DISCOMFORT 1 0.0010
196 BLOOD CREATININE DECREASED 3 0.0010
197 ATRIAL SEPTAL DEFECT 8 0.0010
198 INFUSION SITE ERYTHEMA 8 0.0009
199 BONE DEMINERALISATION 1 0.0009
200 ORTHOPNOEA 3 0.0009
201 ALLERGY TO ANIMAL 1 0.0009
202 HYPERPHOSPHATAEMIA 2 0.0009
203 GASTRIC BYPASS 2 0.0009
204 CLAUSTROPHOBIA 1 0.0009
205 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
206 DENTAL CARIES 10 0.0009
207 AORTIC DILATATION 1 0.0009
208 CHOLESTATIC LIVER INJURY 2 0.0009
209 BLOOD LOSS ANAEMIA 2 0.0009
210 VASCULAR DEVICE INFECTION 4 0.0009
211 PREMATURE DELIVERY 14 0.0009
212 TRANSPLANT REJECTION 7 0.0009
213 ADMINISTRATION SITE PAIN 1 0.0009
214 TACHYCARDIA 77 0.0009
215 MOUTH SWELLING 5 0.0009
216 VAGINAL INFECTION 4 0.0008
217 CHRONIC RESPIRATORY FAILURE 1 0.0008
218 STILLBIRTH 4 0.0008
219 EYE HAEMORRHAGE 11 0.0008
220 BLADDER PROLAPSE 1 0.0008
221 GLOMERULONEPHRITIS 2 0.0008
222 BACK PAIN 189 0.0008
223 ALLERGY TO CHEMICALS 1 0.0008
224 BLADDER DISCOMFORT 1 0.0008
225 MUSCLE TIGHTNESS 13 0.0008
226 HYPERPARATHYROIDISM SECONDARY 2 0.0008
227 PROTEIN TOTAL DECREASED 3 0.0008
228 DYSPNOEA EXERTIONAL 30 0.0008
229 PATHOLOGICAL FRACTURE 4 0.0008
230 DYSLIPIDAEMIA 4 0.0008
231 ENDOCRINE DISORDER 1 0.0008
232 PROCTALGIA 5 0.0008
233 NAIL DISCOLOURATION 3 0.0008
234 RADICULOPATHY 2 0.0008
235 POLYNEUROPATHY 9 0.0008
236 FLANK PAIN 7 0.0007
237 VITAMIN B12 DEFICIENCY 3 0.0007
238 PERIPHERAL VENOUS DISEASE 3 0.0007
239 CARBON DIOXIDE INCREASED 1 0.0007
240 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
241 RED BLOOD CELL COUNT INCREASED 2 0.0007
242 ECHOCARDIOGRAM ABNORMAL 1 0.0007
243 PROCTITIS 2 0.0007
244 MUSCLE FATIGUE 3 0.0007
245 APPENDIX DISORDER 1 0.0007
246 DYSPNOEA 399 0.0007
247 UTERINE HAEMORRHAGE 3 0.0007
248 BLOOD ELECTROLYTES DECREASED 1 0.0007
249 BRAIN FOG 11 0.0007
250 PAIN 430 0.0007
251 NAUSEA 553 0.0007
252 PARAESTHESIA 109 0.0007
253 MUSCLE SPASMS 127 0.0007
254 VOMITING PROJECTILE 2 0.0007
255 ADENOVIRUS INFECTION 2 0.0007
256 VASCULITIS 8 0.0007
257 TONGUE DISCOLOURATION 3 0.0007
258 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
259 HYPERTRIGLYCERIDAEMIA 4 0.0007
260 NEGATIVE THOUGHTS 2 0.0007
261 EAR DISCOMFORT 7 0.0007
262 NECK PAIN 38 0.0007
263 HEAD DISCOMFORT 12 0.0007
264 APRAXIA 1 0.0007
265 ARTHRALGIA 280 0.0007
266 INFUSION SITE REACTION 2 0.0007
267 FEELING HOT 41 0.0007
268 PRURITUS 256 0.0007
269 VARICES OESOPHAGEAL 2 0.0007
270 UNRESPONSIVE TO STIMULI 17 0.0007
271 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
272 DYSAESTHESIA 2 0.0007
273 MUSCLE TWITCHING 15 0.0007
274 CALCULUS URINARY 1 0.0006
275 CHILLS 76 0.0006
276 HYPOMAGNESAEMIA 9 0.0006
277 YELLOW SKIN 3 0.0006
278 SINUS TACHYCARDIA 9 0.0006
279 PREMATURE BABY 19 0.0006
280 PULSE ABSENT 3 0.0006
281 BILE DUCT STONE 2 0.0006
282 SNEEZING 14 0.0006
283 COLD SWEAT 11 0.0006
284 BLOOD CALCIUM DECREASED 7 0.0006
285 CYSTITIS INTERSTITIAL 1 0.0006
286 DIZZINESS 310 0.0006
287 INFLUENZA LIKE ILLNESS 51 0.0006
288 HYPERSENSITIVITY 115 0.0006
289 COSTOCHONDRITIS 1 0.0006
290 INCORRECT DOSAGE ADMINISTERED 3 0.0006
291 PHARYNGEAL SWELLING 6 0.0006
292 ASPERGILLUS INFECTION 4 0.0006
293 BEDRIDDEN 8 0.0006
294 BREATH SOUNDS ABNORMAL 3 0.0006
295 INFUSION SITE HAEMORRHAGE 2 0.0006
296 LISTLESS 2 0.0006
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
298 ANTIBODY TEST POSITIVE 1 0.0006
299 ELECTROLYTE IMBALANCE 7 0.0006
300 BLOOD CALCIUM ABNORMAL 1 0.0006
301 ARTHROPOD STING 1 0.0006
302 JOINT RANGE OF MOTION DECREASED 8 0.0006
303 SENSATION OF FOREIGN BODY 5 0.0006
304 VULVOVAGINAL PRURITUS 3 0.0006
305 TOXIC ENCEPHALOPATHY 3 0.0006
306 HEADACHE 370 0.0006
307 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
308 SUDDEN CARDIAC DEATH 2 0.0006
309 PHLEBITIS 3 0.0006
310 VITAMIN D DECREASED 5 0.0006
311 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
312 BLOOD MAGNESIUM DECREASED 5 0.0006
313 BLOOD CHLORIDE INCREASED 1 0.0006
314 MALABSORPTION 3 0.0006
315 ASTHENIA 216 0.0006
316 HEAVY MENSTRUAL BLEEDING 5 0.0006
317 OROPHARYNGEAL DISCOMFORT 5 0.0006
318 TOOTHACHE 10 0.0006
319 ARRHYTHMIA 26 0.0005
320 ANAPHYLACTIC SHOCK 14 0.0005
321 HYPOAESTHESIA 81 0.0005
322 DENTAL CARE 1 0.0005
323 CARDIAC DYSFUNCTION 2 0.0005
324 DYSENTERY 1 0.0005
325 FIBROMYALGIA 13 0.0005
326 BONE LOSS 8 0.0005
327 HYPOAESTHESIA ORAL 8 0.0005
328 AUTOIMMUNE THYROIDITIS 2 0.0005
329 BLOOD BICARBONATE DECREASED 1 0.0005
330 BLOOD PRESSURE DECREASED 35 0.0005
331 NEUROLOGICAL SYMPTOM 3 0.0005
332 LETHARGY 30 0.0005
333 EXERCISE TOLERANCE DECREASED 3 0.0005
334 ADRENAL DISORDER 1 0.0005
335 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
336 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
337 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
338 HYPOALBUMINAEMIA 4 0.0005
339 ATROPHY 1 0.0005
340 MUSCLE RUPTURE 2 0.0005
341 EPIGASTRIC DISCOMFORT 2 0.0005
342 OESOPHAGEAL PAIN 2 0.0005
343 CELL DEATH 1 0.0005
344 LOW BIRTH WEIGHT BABY 4 0.0005
345 AZOTAEMIA 2 0.0005
346 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
347 BURNING SENSATION 35 0.0005
348 HYPOKALAEMIA 23 0.0005
349 MYASTHENIA GRAVIS 4 0.0005
350 HYPERTENSION 104 0.0005
351 BLOOD PRESSURE INCREASED 75 0.0005
352 BREAST DISORDER 1 0.0005
353 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
354 LIMB DISCOMFORT 15 0.0005
355 SPINAL COMPRESSION FRACTURE 4 0.0005
356 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
357 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
358 BODY TEMPERATURE FLUCTUATION 1 0.0005
359 GASTROENTERITIS 7 0.0005
360 GAIT INABILITY 16 0.0005
361 PAIN IN EXTREMITY 141 0.0005
362 SWELLING OF EYELID 3 0.0005
363 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
364 MUSCLE ATROPHY 6 0.0005
365 RASH 206 0.0005
366 TONGUE DISCOMFORT 2 0.0005
367 AORTIC VALVE INCOMPETENCE 2 0.0005
368 ANAEMIA MACROCYTIC 1 0.0005
369 CATHETER SITE ERYTHEMA 1 0.0005
370 HAEMOGLOBIN ABNORMAL 3 0.0005
371 HEPATIC LESION 2 0.0005
372 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
373 TENDON DISORDER 3 0.0005
374 JOINT STIFFNESS 12 0.0005
375 PARONYCHIA 2 0.0005
376 GASTROINTESTINAL PAIN 5 0.0005
377 GINGIVAL SWELLING 2 0.0005
378 ABDOMINAL ABSCESS 2 0.0005
379 MUSCULOSKELETAL CHEST PAIN 7 0.0005
380 ADENOCARCINOMA 1 0.0004
381 CHRONIC GASTRITIS 1 0.0004
382 EYE INFECTION 5 0.0004
383 RESTLESS LEGS SYNDROME 8 0.0004
384 IMPAIRED DRIVING ABILITY 5 0.0004
385 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
386 ABDOMINAL HERNIA 2 0.0004
387 HAEMOGLOBIN INCREASED 2 0.0004
388 ABDOMINAL PAIN 102 0.0004
389 BILIRUBIN CONJUGATED INCREASED 1 0.0004
390 DIARRHOEA HAEMORRHAGIC 4 0.0004
391 DISCOURAGEMENT 1 0.0004
392 FEELING ABNORMAL 102 0.0004
393 FRACTURE 8 0.0004
394 HAEMOGLOBIN DECREASED 43 0.0004
395 IMPAIRED QUALITY OF LIFE 6 0.0004
396 GRAFT VERSUS HOST DISEASE 3 0.0004
397 SWOLLEN TONGUE 13 0.0004
398 HEART RATE INCREASED 41 0.0004
399 NEURALGIA 10 0.0004
400 BREATH ODOUR 1 0.0004
401 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
402 OXYGEN SATURATION DECREASED 23 0.0004
403 DERMAL CYST 1 0.0004
404 VOMITING 191 0.0004
405 ACUTE PSYCHOSIS 1 0.0004
406 GENERALISED OEDEMA 5 0.0004
407 HAEMATOCRIT DECREASED 8 0.0004
408 DEVICE INFUSION ISSUE 1 0.0004
409 ORTHOSTATIC HYPOTENSION 7 0.0004
410 CATHETER SITE HAEMORRHAGE 1 0.0004
411 VEIN DISORDER 2 0.0004
412 HEART RATE IRREGULAR 9 0.0004
413 DYSPHORIA 2 0.0004
414 CORONARY ARTERIAL STENT INSERTION 2 0.0004
415 ENDODONTIC PROCEDURE 1 0.0004
416 AMMONIA INCREASED 2 0.0004
417 CANCER PAIN 1 0.0004
418 WHEEZING 23 0.0004
419 CATHETER SITE PAIN 1 0.0004
420 PELVIC PAIN 7 0.0004
421 HOT FLUSH 29 0.0004
422 TENDERNESS 4 0.0004
423 MULTIPLE ALLERGIES 3 0.0004
424 HYPERHIDROSIS 49 0.0004
425 BLOOD ALBUMIN DECREASED 3 0.0004
426 OEDEMA PERIPHERAL 46 0.0004
427 IMPAIRED WORK ABILITY 8 0.0004
428 COMPRESSION FRACTURE 2 0.0004
429 EAR CONGESTION 1 0.0004
430 RESPIRATORY DISORDER 11 0.0004
431 POLYURIA 3 0.0004
432 PULMONARY FIBROSIS 7 0.0004
433 ESCHERICHIA INFECTION 3 0.0004
434 PERIPHERAL COLDNESS 5 0.0004
435 CHOKING SENSATION 2 0.0004
436 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
437 RESPIRATORY DISTRESS 10 0.0004
438 FEELING COLD 10 0.0004
439 HYPOTENSION 72 0.0004
440 PYREXIA 124 0.0004
441 ENDOTRACHEAL INTUBATION 1 0.0004
442 MENORRHAGIA 7 0.0004
443 NEPHROPATHY TOXIC 4 0.0004
444 PERIORBITAL SWELLING 2 0.0004
445 TINNITUS 16 0.0003
446 RASH GENERALISED 9 0.0003
447 MYOPATHY 3 0.0003
448 RESPIRATORY TRACT INFECTION 9 0.0003
449 HYPERVENTILATION 2 0.0003
450 STRESS CARDIOMYOPATHY 2 0.0003
451 POST PROCEDURAL HAEMORRHAGE 4 0.0003
452 MUSCULAR WEAKNESS 39 0.0003
453 HYPOVOLAEMIA 2 0.0003
454 GRIP STRENGTH DECREASED 3 0.0003
455 PANCYTOPENIA 19 0.0003
456 RESPIRATORY RATE INCREASED 3 0.0003
457 EXPOSURE DURING PREGNANCY 21 0.0003
458 PLEURISY 2 0.0003
459 FACIAL PAIN 3 0.0003
460 CREPITATIONS 1 0.0003
461 MALAISE 147 0.0003
462 DISTURBANCE IN ATTENTION 18 0.0003
463 ANAL INCONTINENCE 3 0.0003
464 HEPATITIS CHOLESTATIC 2 0.0003
465 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
466 PERIPHERAL SWELLING 51 0.0003
467 ERYTHEMA 68 0.0003
468 PALLOR 9 0.0003
469 FOETAL GROWTH RESTRICTION 2 0.0003
470 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
471 INCREASED TENDENCY TO BRUISE 3 0.0003
472 PAIN IN JAW 9 0.0003
473 BREAST CANCER RECURRENT 1 0.0003
474 RASH PAPULAR 7 0.0003
475 SENSORY DISTURBANCE 5 0.0003
476 SINUS BRADYCARDIA 3 0.0003
477 ORAL HERPES 6 0.0003
478 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
479 PRODUCT PREPARATION ISSUE 2 0.0003
480 HOSPICE CARE 3 0.0003
481 PERICARDIAL EFFUSION 7 0.0003
482 BLOOD PRESSURE ABNORMAL 6 0.0003
483 HYPOTONIA 3 0.0003
484 ANXIETY DISORDER 1 0.0003
485 TOXIC SKIN ERUPTION 3 0.0003
486 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
487 TACHYPNOEA 4 0.0003
488 EYE MOVEMENT DISORDER 2 0.0003
489 SWELLING FACE 19 0.0003
490 NEPHROTIC SYNDROME 2 0.0003
491 ECCHYMOSIS 2 0.0003
492 SKIN LESION 8 0.0003
493 TEMPERATURE INTOLERANCE 3 0.0003
494 MUSCULOSKELETAL DISCOMFORT 5 0.0003
495 JOINT EFFUSION 2 0.0003
496 ENCEPHALITIS 2 0.0003
497 VENTRICULAR EXTRASYSTOLES 3 0.0003
498 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
499 PETECHIAE 3 0.0003
500 FORMICATION 2 0.0003
501 FEBRILE NEUTROPENIA 19 0.0003
502 TRANSFUSION 3 0.0003
503 RASH MACULAR 10 0.0003
504 RIGHT VENTRICULAR FAILURE 2 0.0003
505 EOSINOPHILIA 5 0.0003
506 RENAL PAIN 3 0.0003
507 LYMPHOCYTE COUNT DECREASED 5 0.0003
508 DYSGEUSIA 21 0.0003
509 SEASONAL ALLERGY 4 0.0003
510 CONJUNCTIVAL HYPERAEMIA 1 0.0003
511 MOVEMENT DISORDER 9 0.0003
512 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
513 GOUT 5 0.0003
514 DISCOMFORT 17 0.0003
515 PRURITUS GENERALISED 6 0.0003
516 OEDEMA 15 0.0003
517 TONGUE DISORDER 2 0.0003
518 OSTEONECROSIS 9 0.0003
519 MAJOR DEPRESSION 2 0.0003
520 MELAENA 6 0.0003
521 BLINDNESS TRANSIENT 2 0.0003
522 SYNCOPE 27 0.0003
523 EYE SWELLING 10 0.0003
524 COLON CANCER 4 0.0003
525 ABDOMINAL PAIN UPPER 55 0.0003
526 GAIT DISTURBANCE 51 0.0003
527 PRODUCT USE IN UNAPPROVED INDICATION 66 0.0003
528 FOOT FRACTURE 5 0.0003
529 INSURANCE ISSUE 4 0.0003
530 FATIGUE 203 0.0003
531 PHARYNGEAL OEDEMA 4 0.0003
532 RASH PRURITIC 14 0.0003
533 LOSS OF CONSCIOUSNESS 33 0.0003
534 CERVIX CARCINOMA 1 0.0003
535 RENAL CYST 2 0.0003
536 ANAEMIA 48 0.0003
537 MUSCULOSKELETAL STIFFNESS 22 0.0003
538 ADVERSE EVENT 23 0.0002
539 SENSORY LOSS 2 0.0002
540 FRUSTRATION TOLERANCE DECREASED 2 0.0002
541 HYPOGLYCAEMIA 12 0.0002
542 VERTIGO 15 0.0002
543 POST PROCEDURAL INFECTION 2 0.0002
544 AMNESIA 16 0.0002
545 SWELLING 23 0.0002
546 SHOCK HAEMORRHAGIC 2 0.0002
547 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
548 ENCEPHALOPATHY 6 0.0002
549 MULTIPLE FRACTURES 4 0.0002
550 HYPERAESTHESIA 2 0.0002
551 MENSTRUAL DISORDER 2 0.0002
552 TOOTH LOSS 5 0.0002
553 SLEEP DISORDER 17 0.0002
554 EPISTAXIS 18 0.0002
555 VISION BLURRED 33 0.0002
556 LIP SWELLING 8 0.0002
557 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
558 FACE OEDEMA 4 0.0002
559 HEPATIC ENZYME INCREASED 16 0.0002
560 RETCHING 5 0.0002
561 SKIN HYPERPIGMENTATION 2 0.0002
562 ABNORMAL SENSATION IN EYE 1 0.0002
563 ANURIA 2 0.0002
564 NEUROPATHY PERIPHERAL 22 0.0002
565 MUSCLE STRAIN 2 0.0002
566 HYSTERECTOMY 2 0.0002
567 MIGRAINE 22 0.0002
568 CHAPPED LIPS 1 0.0002
569 RASH ERYTHEMATOUS 11 0.0002
570 PRODUCT PRESCRIBING ISSUE 5 0.0002
571 MUSCULOSKELETAL PAIN 12 0.0002
572 URINE OUTPUT DECREASED 2 0.0002
573 HEART RATE DECREASED 8 0.0002
574 SPINAL OSTEOARTHRITIS 2 0.0002
575 TOOTH INFECTION 3 0.0002
576 PRODUCT COMMUNICATION ISSUE 2 0.0002
577 SEIZURE 26 0.0002
578 TOOTH DISORDER 5 0.0002
579 NERVOUS SYSTEM DISORDER 7 0.0002
580 TREMOR 37 0.0002
581 ADVERSE DRUG REACTION 20 0.0002
582 SINUS CONGESTION 3 0.0002
583 CHROMATURIA 5 0.0002
584 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
585 PRODUCT AVAILABILITY ISSUE 5 0.0002
586 EAR DISORDER 1 0.0002
587 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
588 COGNITIVE DISORDER 10 0.0002
589 DYSPEPSIA 21 0.0002
590 HEPATIC CIRRHOSIS 4 0.0002
591 CARDIAC FAILURE 17 0.0002
592 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
593 RECALLED PRODUCT ADMINISTERED 2 0.0002
594 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
595 LOCALISED INFECTION 5 0.0002
596 EAR PAIN 4 0.0002
597 DYSPHONIA 12 0.0002
598 COELIAC DISEASE 2 0.0002
599 KIDNEY INFECTION 4 0.0002
600 HEPATOMEGALY 2 0.0002
601 BODY TEMPERATURE DECREASED 2 0.0002
602 LIGAMENT SPRAIN 2 0.0002
603 ABDOMINAL TENDERNESS 1 0.0002
604 ANEURYSM 1 0.0002
605 SPINAL FRACTURE 4 0.0002
606 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
607 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
608 CONTUSION 19 0.0002
609 MOTOR DYSFUNCTION 2 0.0002
610 HYPOPHAGIA 5 0.0002
611 DEVICE RELATED INFECTION 3 0.0002
612 OSTEOPOROSIS 8 0.0002
613 RENAL DISORDER 9 0.0002
614 PULMONARY HYPERTENSION 4 0.0002
615 BLOOD LACTIC ACID INCREASED 1 0.0002
616 OSTEOARTHRITIS 8 0.0002
617 BRADYCARDIA 10 0.0002
618 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
619 SCIATICA 3 0.0002
620 DIARRHOEA 121 0.0002
621 LIVER FUNCTION TEST INCREASED 4 0.0002
622 BLOOD BILIRUBIN INCREASED 5 0.0002
623 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
624 FAECES DISCOLOURED 4 0.0002
625 LIMB INJURY 5 0.0002
626 BACK INJURY 2 0.0002
627 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
628 TOOTH FRACTURE 2 0.0002
629 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
630 MENTAL STATUS CHANGES 5 0.0002
631 DYSPHAGIA 17 0.0002
632 ORAL PAIN 4 0.0002
633 EYE PRURITUS 6 0.0002
634 RENAL IMPAIRMENT 15 0.0002
635 ANGIOPATHY 1 0.0002
636 CONDITION AGGRAVATED 54 0.0002
637 HYPONATRAEMIA 10 0.0002
638 STATUS EPILEPTICUS 2 0.0002
639 DISORIENTATION 7 0.0002
640 CHOLECYSTITIS ACUTE 1 0.0002
641 DERMATITIS CONTACT 2 0.0002
642 SCAB 2 0.0002
643 INTERNAL HAEMORRHAGE 2 0.0002
644 CARDIAC VALVE DISEASE 1 0.0002
645 HYPERSOMNIA 5 0.0002
646 GASTRIC HAEMORRHAGE 2 0.0002
647 METASTASES TO LUNG 2 0.0002
648 DECREASED APPETITE 40 0.0002
649 LOCAL SWELLING 3 0.0002
650 NEUROTOXICITY 3 0.0002
651 SPINAL PAIN 2 0.0002
652 ACUTE MYOCARDIAL INFARCTION 5 0.0002
653 LABORATORY TEST ABNORMAL 5 0.0002
654 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
655 THIRST 3 0.0002
656 MYOCLONUS 2 0.0002
657 CARDIO-RESPIRATORY ARREST 7 0.0002
658 CONFUSIONAL STATE 27 0.0002
659 IRRITABILITY 10 0.0002
660 BLOOD POTASSIUM DECREASED 5 0.0002
661 HYPERGLYCAEMIA 6 0.0002
662 BONE DISORDER 3 0.0002
663 DERMATITIS ACNEIFORM 1 0.0002
664 RESTLESSNESS 6 0.0002
665 INJECTION SITE RASH 5 0.0002
666 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
667 HYPERCALCAEMIA 2 0.0002
668 ABASIA 4 0.0002
669 ILEUS 2 0.0002
670 COLITIS 6 0.0002
671 ABDOMINAL PAIN LOWER 4 0.0002
672 GASTRIC ULCER 3 0.0002
673 COUGH 44 0.0002
674 HEPATIC CYTOLYSIS 2 0.0002
675 COLITIS ULCERATIVE 7 0.0002
676 HYPOTHYROIDISM 5 0.0002
677 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
678 HEPATITIS 4 0.0002
679 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
680 ABDOMINAL DISCOMFORT 26 0.0002
681 CARDIAC FLUTTER 1 0.0002
682 BREAST CANCER STAGE III 1 0.0002
683 NEPHROLITHIASIS 7 0.0002
684 GASTRITIS 4 0.0002
685 DYSMENORRHOEA 2 0.0002
686 APPETITE DISORDER 1 0.0002
687 BALANCE DISORDER 13 0.0002
688 EAR INFECTION 4 0.0002
689 CARDIAC FAILURE ACUTE 1 0.0001
690 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
691 CHOLECYSTITIS CHRONIC 1 0.0001
692 QUALITY OF LIFE DECREASED 2 0.0001
693 STOMATITIS 9 0.0001
694 FEEDING DISORDER 3 0.0001
695 OCULAR HYPERAEMIA 7 0.0001
696 BODY TEMPERATURE INCREASED 3 0.0001
697 IMPAIRED GASTRIC EMPTYING 2 0.0001
698 ABNORMAL LOSS OF WEIGHT 1 0.0001
699 GINGIVAL BLEEDING 2 0.0001
700 ILLNESS 15 0.0001
701 PERITONITIS 3 0.0001
702 SEPSIS 16 0.0001
703 COORDINATION ABNORMAL 2 0.0001
704 CARPAL TUNNEL SYNDROME 2 0.0001
705 DEFAECATION URGENCY 1 0.0001
706 BLOOD TEST ABNORMAL 2 0.0001
707 CONSTIPATION 31 0.0001
708 HALLUCINATION, VISUAL 3 0.0001
709 HEPATOCELLULAR INJURY 2 0.0001
710 JOINT SWELLING 17 0.0001
711 BRONCHOSPASM 2 0.0001
712 RED BLOOD CELL COUNT DECREASED 4 0.0001
713 RECTAL HAEMORRHAGE 6 0.0001
714 ANGINA PECTORIS 4 0.0001
715 MOBILITY DECREASED 10 0.0001
716 DRUG INTERACTION 22 0.0001
717 SURGERY 8 0.0001
718 CEREBRAL DISORDER 1 0.0001
719 STEVENS-JOHNSON SYNDROME 3 0.0001
720 HEPATOTOXICITY 3 0.0001
721 THERAPY NON-RESPONDER 6 0.0001
722 HEPATIC FAILURE 4 0.0001
723 OSTEOPENIA 2 0.0001
724 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
725 AORTIC ANEURYSM 1 0.0001
726 ACIDOSIS 1 0.0001
727 DISSOCIATION 1 0.0001
728 EJECTION FRACTION DECREASED 2 0.0001
729 CYANOSIS 2 0.0001
730 HAEMATOCHEZIA 7 0.0001
731 DRUG SCREEN POSITIVE 1 0.0001
732 ATRIAL FLUTTER 1 0.0001
733 HEPATIC CANCER 3 0.0001
734 ABORTION SPONTANEOUS 5 0.0001
735 HIP FRACTURE 4 0.0001
736 RESPIRATORY FAILURE 9 0.0001
737 DECUBITUS ULCER 1 0.0001
738 ASPHYXIA 1 0.0001
739 INJECTION SITE URTICARIA 3 0.0001
740 LIVER INJURY 3 0.0001
741 ALOPECIA 24 0.0001
742 MANIA 2 0.0001
743 VENTRICULAR TACHYCARDIA 2 0.0001
744 PHOTOSENSITIVITY REACTION 2 0.0001
745 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
746 COAGULOPATHY 2 0.0001
747 SKIN DISORDER 4 0.0001
748 POLLAKIURIA 5 0.0001
749 INJECTION SITE PRURITUS 8 0.0001
750 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
751 OROPHARYNGEAL PAIN 11 0.0001
752 HAEMATEMESIS 3 0.0001
753 PNEUMONIA 38 0.0001
754 HAEMATURIA 4 0.0001
755 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
756 CARDIAC OPERATION 1 0.0001
757 CARDIAC MURMUR 1 0.0001
758 DIPLOPIA 3 0.0001
759 DELIRIUM 4 0.0001
760 PLEURAL EFFUSION 7 0.0001
761 HAEMORRHAGE 12 0.0001
762 SOMNOLENCE 23 0.0001
763 AMENORRHOEA 2 0.0001
764 DRUG ERUPTION 2 0.0001
765 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
766 MENSTRUATION IRREGULAR 3 0.0001
767 PULMONARY OEDEMA 5 0.0001
768 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
769 FREQUENT BOWEL MOVEMENTS 3 0.0001
770 OSTEOMYELITIS 2 0.0001
771 CRYING 4 0.0001
772 BRONCHITIS 8 0.0001
773 HEPATIC STEATOSIS 2 0.0001
774 APPENDICITIS 1 0.0001
775 PRODUCT USE ISSUE 20 0.0001
776 ABORTION INDUCED 1 0.0001
777 INTESTINAL OBSTRUCTION 4 0.0001
778 DEPRESSION 24 0.0001
779 ABDOMINAL DISTENSION 11 0.0001
780 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
781 PROTEINURIA 2 0.0001
782 DEHYDRATION 14 0.0001
783 ACUTE RESPIRATORY FAILURE 2 0.0001
784 ATELECTASIS 1 0.0001
785 ERUCTATION 2 0.0001
786 DIZZINESS POSTURAL 1 0.0001
787 DYSSTASIA 3 0.0001
788 AUTOIMMUNE DISORDER 1 0.0001
789 HAEMORRHOIDS 2 0.0001
790 NASAL CONGESTION 6 0.0001
791 LUNG DISORDER 5 0.0001
792 ARTHRITIS 8 0.0001
793 DISEASE PROGRESSION 12 0.0001
794 RENAL INJURY 3 0.0001
795 PREGNANCY 2 0.0001
796 URINARY TRACT INFECTION 17 0.0001
797 APHASIA 3 0.0001
798 FULL BLOOD COUNT DECREASED 2 0.0001
799 CELLULITIS 5 0.0001
800 PRODUCT ADMINISTRATION ERROR 2 0.0001
801 TASTE DISORDER 2 0.0001
802 DRY THROAT 1 0.0001
803 FLUID RETENTION 5 0.0001
804 INSOMNIA 26 0.0001
805 EMOTIONAL DISORDER 3 0.0001
806 COVID-19 17 0.0001
807 INFECTION 14 0.0001
808 TREATMENT FAILURE 8 0.0001
809 FALL 32 0.0001
810 HEAD INJURY 3 0.0001
811 BREAST CANCER METASTATIC 1 0.0001
812 RHINORRHOEA 6 0.0001
813 DECREASED ACTIVITY 1 0.0001
814 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
815 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
816 INJECTION SITE SWELLING 7 0.0001
817 ASPIRATION 1 0.0001
818 STAPHYLOCOCCAL INFECTION 3 0.0001
819 LIVER DISORDER 4 0.0001
820 VIRAL INFECTION 3 0.0001
821 FUNGAL INFECTION 3 0.0001
822 ARTHROPATHY 5 0.0001
823 INFLUENZA 10 0.0001
824 GLOSSODYNIA 2 0.0001
825 EYE PAIN 5 0.0001
826 CHOLECYSTECTOMY 1 0.0001
827 SHOCK 2 0.0001
828 CARDIAC DISORDER 8 0.0001
829 HYPOXIA 3 0.0001
830 CARDIAC ARREST 7 0.0001
831 LYMPHADENOPATHY 3 0.0001
832 COVID-19 PNEUMONIA 1 0.0001
833 HOSPITALISATION 13 0.0001
834 PLATELET COUNT DECREASED 9 0.0001
835 BACTERAEMIA 1 0.0001
836 CHOLECYSTITIS 1 0.0001
837 BLOOD PRESSURE FLUCTUATION 2 0.0001
838 BLOOD GLUCOSE DECREASED 4 0.0001
839 MENTAL IMPAIRMENT 2 0.0001
840 DYSURIA 3 0.0001
841 CARDIOMEGALY 1 0.0001
842 DYSARTHRIA 3 0.0001
843 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
844 BRAIN OEDEMA 1 0.0001
845 GASTRIC CANCER 2 0.0001
846 GASTROINTESTINAL DISORDER 7 0.0001
847 SINUSITIS 8 0.0001
848 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
849 INFLAMMATION 4 0.0001
850 HAEMATOMA 2 0.0001
851 DEEP VEIN THROMBOSIS 5 0.0001
852 MUCOSAL INFLAMMATION 2 0.0001
853 ANKYLOSING SPONDYLITIS 1 0.0001
854 PANCREATITIS 4 0.0001
855 RENAL FAILURE 10 0.0001
856 WEIGHT DECREASED 21 0.0001
857 INJECTION SITE BRUISING 6 0.0001
858 PAIN OF SKIN 2 0.0001
859 OFF LABEL USE 65 0.0001
860 DYSKINESIA 3 0.0001
861 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
862 BLINDNESS 3 0.0001
863 NEUTROPHIL COUNT DECREASED 3 0.0001
864 AKATHISIA 1 0.0001
865 TREATMENT NONCOMPLIANCE 4 0.0001
866 VISUAL IMPAIRMENT 9 0.0001
867 RESPIRATORY ARREST 2 0.0001
868 DRUG INTOLERANCE 7 0.0001
869 DIVERTICULITIS 2 0.0001
870 MEDICATION ERROR 4 0.0001
871 RHABDOMYOLYSIS 3 0.0001
872 ATRIAL FIBRILLATION 7 0.0001
873 ACUTE KIDNEY INJURY 11 0.0001
874 DEMENTIA 2 0.0001
875 THROMBOCYTOPENIA 8 0.0001
876 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
877 DIALYSIS 1 0.0001
878 THERAPY INTERRUPTED 5 0.0001
879 VAGINAL HAEMORRHAGE 3 0.0001
880 MENTAL DISORDER 3 0.0001
881 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
882 ASCITES 2 0.0001
883 ANGIOEDEMA 3 0.0001
884 URINARY INCONTINENCE 2 0.0001
885 LACRIMATION INCREASED 2 0.0001
886 NEUTROPENIA 9 0.0001
887 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
888 BLOOD COUNT ABNORMAL 1 0.0001
889 MEMORY IMPAIRMENT 9 0.0001
890 EPILEPSY 2 0.0001
891 DEVICE ADHESION ISSUE 1 0.0001
892 ACUTE MYELOID LEUKAEMIA 1 0.0001
893 BASAL CELL CARCINOMA 1 0.0001
894 PULMONARY EMBOLISM 6 0.0001
895 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
896 PRODUCTIVE COUGH 3 0.0001
897 CARDIAC FAILURE CONGESTIVE 5 0.0001
898 ASTHMA 7 0.0001
899 BACK DISORDER 1 0.0001
900 PRODUCT DOSE OMISSION 4 0.0001
901 BLOOD CREATININE INCREASED 4 0.0001
902 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
903 LEUKOPENIA 3 0.0001
904 NEOPLASM MALIGNANT 4 0.0001
905 BLOOD UREA INCREASED 1 0.0001
906 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
907 INJECTION SITE PAIN 18 0.0001
908 THERAPY CESSATION 3 0.0001
909 INJECTION SITE REACTION 4 0.0001
910 WEIGHT INCREASED 13 0.0001
911 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
912 SPEECH DISORDER 3 0.0001
913 HYPERKALAEMIA 2 0.0001
914 INCORRECT DOSE ADMINISTERED 13 0.0001
915 DEPRESSED MOOD 3 0.0001
916 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
917 INJECTION SITE ERYTHEMA 7 0.0001
918 PRODUCT ADHESION ISSUE 2 0.0001
919 CEREBRAL HAEMORRHAGE 2 0.0001
920 DRUG EFFECT DECREASED 3 0.0001
921 PANIC ATTACK 2 0.0001
922 ACCIDENTAL OVERDOSE 2 0.0001
923 BLOOD GLUCOSE ABNORMAL 1 0.0001
924 INJECTION SITE MASS 2 0.0001
925 HEPATIC FUNCTION ABNORMAL 2 0.0001
926 BLISTER 3 0.0001
927 BLOOD SODIUM DECREASED 1 0.0001
928 UNEVALUABLE EVENT 4 0.0001
929 RHEUMATOID ARTHRITIS 6 0.0001
930 CHRONIC KIDNEY DISEASE 4 0.0001
931 HERPES ZOSTER 3 0.0001
932 CHOLESTASIS 1 0.0001
933 DRUG INEFFECTIVE 68 0.0001
934 CHOKING 1 0.0001
935 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
936 ABNORMAL BEHAVIOUR 2 0.0001
937 CYTOKINE RELEASE SYNDROME 1 0.0000
938 DRY MOUTH 4 0.0000
939 DERMATITIS 1 0.0000
940 WITHDRAWAL SYNDROME 2 0.0000
941 SEPTIC SHOCK 2 0.0000
942 PRODUCT STORAGE ERROR 4 0.0000
943 DEATH 39 0.0000
944 NO ADVERSE EVENT 8 0.0000
945 APPLICATION SITE PRURITUS 1 0.0000
946 SKIN IRRITATION 2 0.0000
947 BLOOD GLUCOSE INCREASED 8 0.0000
948 DIABETIC KETOACIDOSIS 1 0.0000
949 CEREBROVASCULAR ACCIDENT 7 0.0000
950 INTERSTITIAL LUNG DISEASE 2 0.0000
951 AGEUSIA 1 0.0000
952 HALLUCINATION 3 0.0000
953 NERVOUSNESS 2 0.0000
954 DEAFNESS 1 0.0000
955 PRODUCT DOSE OMISSION ISSUE 11 0.0000
956 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
957 FLATULENCE 2 0.0000
958 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
959 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
960 CORONARY ARTERY DISEASE 1 0.0000
961 DRUG ADMINISTRATION ERROR 1 0.0000
962 DRUG-INDUCED LIVER INJURY 1 0.0000
963 CYSTITIS 1 0.0000
964 CHOLELITHIASIS 1 0.0000
965 DRY SKIN 4 0.0000
966 DEVICE USE ERROR 1 0.0000
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
968 OVERDOSE 6 0.0000
969 C-REACTIVE PROTEIN INCREASED 1 0.0000
970 UNDERDOSE 2 0.0000
971 AGITATION 2 0.0000
972 DIABETES MELLITUS 2 0.0000
973 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
974 THROMBOSIS 2 0.0000
975 DEVICE BREAKAGE 1 0.0000
976 DEVICE DISLOCATION 1 0.0000
977 MYOCARDIAL INFARCTION 4 0.0000
978 NASOPHARYNGITIS 4 0.0000
979 BLOOD CHOLESTEROL INCREASED 1 0.0000
980 DISEASE RECURRENCE 1 0.0000
981 COMA 1 0.0000
982 DRY EYE 1 0.0000
983 ECZEMA 1 0.0000
984 CONVULSION 1 0.0000
985 BLADDER CANCER 1 0.0000
986 ACNE 1 0.0000
987 TOXICITY TO VARIOUS AGENTS 2 0.0000
988 DRUG WITHDRAWAL SYNDROME 1 0.0000
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
990 DRUG DEPENDENCE 1 0.0000
991 DRUG DOSE OMISSION 1 0.0000